MedTrace Logo

Oral Gabapentin and Median Nerve Mobilization in the Treatment of Carpal Tunnel Syndrome

NCT04285281 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 126

Last updated 2025-12-10

No results posted yet for this study

Summary

The present randomized clinical trial will perform a comparison of the pain reduction effects produced by the application of a non invasive and non pharmacological median nerve neural mobilization (physiotherapy treatment), to those effects produced by Gabapentin and the absence of treatment, in subjects who suffer the signs and symptoms of carpal tunnel syndrome.

Conditions

  • Carpal Tunnel Syndrome

Interventions

DRUG

Gabapentin oral capsules

Oral capsule pharmaceutical treatment.

OTHER

Median nerve neural mobilization

Manual therapy maneuver performed in the upper limb.

Sponsors & Collaborators

  • Universidad Europea de Madrid

    lead OTHER

Principal Investigators

  • Francisco Unda, PhD · Confederación Gallega de Discapacidad

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
QUADRUPLE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-04-01
Primary Completion
2020-08-01
Completion
2020-08-10

Countries

  • Venezuela

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT04285281 on ClinicalTrials.gov